Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025
PRINCETON, N.J., April 18, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:…
Verdantis Launches Next-Gen AI Solutions to Transform Enterprise Master Data Management
Auto-Enrich AI and Auto-Spec AI Redefine Data Integrity, Enrichment, and Operational Efficiency…
Adstra Introduces Composable Identity Solution to Fill the Gaps in the Modern Data Stack
With Conexa, Brands Can Approach Identity on Their Own Terms February 25,…
ANI Pharmaceuticals to Present at Raymond James Institutional Investors and Leerink Partners Global Healthcare Conferences in March
February 19, 2025 16:30 ET | Source: ANI Pharmaceuticals, Inc. PRINCETON, N.J.,…
U.S. Food and Drug Administration Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo (nivolumab) Indications1,2
Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1 Given…
CitiusTech Awarded a 2024 AWS Partner Award
PRINCETON, N.J.--(BUSINESS WIRE)--#AWS--CitiusTech, a leading provider of healthcare technology, services & solutions,…